参考文献/References:
[1]Mirzayev F,Viney K,Linh NN,et al.World Health Organization recommendations on the treatment of drug-resistant tuberculosis,2020 update[J].Eur Respir J,2021,57(6):2003300.[2]Guo Z,Xiao D,Wang X,et al.Epidemiological characteristics of pulmonary tuberculosis in mainland China from 2004 to 2015: a model-based analysis[J].BMC Public Health,2019,19(1):219.[3]Shen T,Liu YX,Shang J,et al.Incidence and Etiology of Drug-Induced Liver Injury in Mainland China[J].Gastroenterology,2019,156(8):2230-2241.[4]金小琳,杨智彬,詹淑华,等.1501例初治住院结核病患者肝功能异常的影响因素[J].中华实验和临床感染病杂志(电子版),2020,14(5):394-400.[5]李凌未,马凌飞,李胜前.412例抗结核药物导致肝损害的临床评价分析[J].药物流行病学杂志,2016,25(12):773-776．[6]中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS288-2017)[J].新发传染病电子杂志,2018,3(1):59-61．[7]Yu YC,Mao YM,Chen CW,et al.CSH guidelines for the diagnosis and treatment of drug-induced liver injury[J].Hepatol Int,2017,11(3):221-241.[8]中华医学会结核病学分会.抗结核药物性肝损伤诊治指南(2019年版)[J].中华结核和呼吸杂志,2019,42(5):343-356.[9]朱汉秋.2019-2020年江西省德兴市肺结核患病状况及流行病学特征调查[J].现代诊断与治疗,2021,32(20):3315-3316. [10]陈柳燕,李萍,周建虎,等.2014-2019年银川市老年人肺结核流行特征分析[J].宁夏医学杂志,2021,43(9):858-860.[11]Zhang CY,Zhao F,Xia YY,et al.Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study[J].Infectious Diseases of Poverty,2019,8(1):7.[12]Danjuma MI,Almasri H,Alshokri S,et al.Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score[J].BMC Geriatr,2020,20(1):2-8.[13]Aiso M,Takikawa H,Tsuji K,et al.Analysis of 307 cases with druginduced liver injury between 2010 and 2018 in Japan[J].Hepatol Res,2019,49(1):105-110. [14]George N,Chen M,Yuen N,et al.Interplay of gender, age and drug properties on reporting frequency of druginduced liver injury[J].Regul Toxicol Pharmacol,2018,94:101-107,[15]Raschi E,De Ponti F.Drug-induced liver injury：Towards early prediction and risk stratification[J].World J Hepatol,2017,9(1):30-37.[16]Bright-Thomas RJ,Gondker AR,Morris J,et al.Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period[J].Int J Tuberc Lung Dis,2016,20(12):1621-1624.[17]Gardner Toren K,Spitters C,Pecha M,et al.Tuberculosis in Older Adults: Seattle & King County,Washington[J].Clin Infect Dis,2020,70(6):1202-1207.[18]于乐成,陈成伟.药物性肝损伤的发生机制:当前认识和未来需求[J].临床肝胆病杂志,2021,37(11):2515-2524．[19]European Association for the Study of the Liver.EASL clinical practice guidelines: Drug - induced liver injury[J].J Hepatol,2019,70(6):1222-1261.[20]Lucena MI,Sanabria J,García-Cortes M,et al.Drug-induced liver injury in older people[J].Lancet Gastroenterol Hepatol,2020,5(9):862-874.[21]王超,郭立杰,张海丛,等.初治结核病患者预防使用保肝药物对药物性肝损伤的价值研究[J].临床误诊误治,2019,32(9):21-26.[22]冯地忠,官正喜,蒋锋,等.预防性保肝对居家治疗结核患者肝损伤的疗效观察[J].解放军预防医学杂志,2020,38(3):52-54.[23]Kim WS,Lee SS,Lee CM,et al.Hepatitis C and not hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury[J].BMC Infect Dis,2016,1(16):50.[24]Tweed CD,Wills GH,Crook AM,et al.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study[J].BMC Med,2018,16(1):46.